These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 9311993

  • 21. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL, Hsu JW, Liu MC, Chen LY, Chang CD.
    Exp Cell Res; 2000 Aug 01; 258(2):322-31. PubMed ID: 10896783
    [Abstract] [Full Text] [Related]

  • 22. Role of proteasomes in T cell activation and proliferation.
    Wang X, Luo H, Chen H, Duguid W, Wu J.
    J Immunol; 1998 Jan 15; 160(2):788-801. PubMed ID: 9551914
    [Abstract] [Full Text] [Related]

  • 23. Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction of p27Xic1.
    Swanson C, Ross J, Jackson PK.
    Proc Natl Acad Sci U S A; 2000 Jul 05; 97(14):7796-801. PubMed ID: 10884410
    [Abstract] [Full Text] [Related]

  • 24. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S.
    Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451
    [Abstract] [Full Text] [Related]

  • 25. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
    Mann DJ, Child ES, Swanton C, Laman H, Jones N.
    EMBO J; 1999 Feb 01; 18(3):654-63. PubMed ID: 9927425
    [Abstract] [Full Text] [Related]

  • 26. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J.
    Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512
    [Abstract] [Full Text] [Related]

  • 27. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.
    Delmas C, Manenti S, Boudjelal A, Peyssonnaux C, Eychène A, Darbon JM.
    J Biol Chem; 2001 Sep 14; 276(37):34958-65. PubMed ID: 11418594
    [Abstract] [Full Text] [Related]

  • 28. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW, Montalvo E, Massagué J.
    J Biol Chem; 1997 Oct 10; 272(41):25863-72. PubMed ID: 9325318
    [Abstract] [Full Text] [Related]

  • 29. Role of p27(Kip1) in human intestinal cell differentiation.
    Deschênes C, Vézina A, Beaulieu JF, Rivard N.
    Gastroenterology; 2001 Feb 10; 120(2):423-38. PubMed ID: 11159883
    [Abstract] [Full Text] [Related]

  • 30. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
    Albrecht JH, Rieland BM, Nelsen CJ, Ahonen CL.
    Am J Physiol; 1999 Dec 10; 277(6):G1207-16. PubMed ID: 10600818
    [Abstract] [Full Text] [Related]

  • 31. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O.
    Hepatology; 1999 Feb 10; 29(2):385-95. PubMed ID: 9918914
    [Abstract] [Full Text] [Related]

  • 32. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest.
    Loubat A, Rochet N, Turchi L, Rezzonico R, Far DF, Auberger P, Rossi B, Ponzio G.
    Oncogene; 1999 Jun 03; 18(22):3324-33. PubMed ID: 10362353
    [Abstract] [Full Text] [Related]

  • 33. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G.
    Mol Cell Biol; 1999 Mar 03; 19(3):1981-9. PubMed ID: 10022885
    [Abstract] [Full Text] [Related]

  • 34. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L, Swanson C, Kaiser BK, Eldridge AG, Jackson PK.
    Nat Cell Biol; 2001 Aug 03; 3(8):715-22. PubMed ID: 11483956
    [Abstract] [Full Text] [Related]

  • 35. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA, Boldogh I, Ma T, Albrecht T, Thompson EA.
    Cell Growth Differ; 1996 Oct 03; 7(10):1283-90. PubMed ID: 8891332
    [Abstract] [Full Text] [Related]

  • 36. Effects of cyclin D1 overexpression on G1 progression-related events.
    Imoto M, Doki Y, Jiang W, Han EK, Weinstein IB.
    Exp Cell Res; 1997 Oct 10; 236(1):173-80. PubMed ID: 9344597
    [Abstract] [Full Text] [Related]

  • 37. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60.
    Müller D, Thieke K, Bürgin A, Dickmanns A, Eilers M.
    EMBO J; 2000 May 15; 19(10):2168-80. PubMed ID: 10811608
    [Abstract] [Full Text] [Related]

  • 38. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 05; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 40. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts.
    Kilbey A, Stephens V, Bartholomew C.
    Cell Growth Differ; 1999 Sep 05; 10(9):601-10. PubMed ID: 10511310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.